Abstract: Proposed are a plastic foam product added with EVA recycled pellets and a method of manufacturing the same, in which there is provided a process for manufacturing a shoe sole by recycling shoe molding waste generated due to defective judgment during a shoe manufacturing process and used shoe waste discarded after use of finished shoe products, thereby allowing shoe manufacturing to meet the trend of pursuing eco-friendly products in Korea and in markets such as Europe, and there is provided a process in which dispersion between materials is strengthened in the process of manufacturing a plastic foam product by adding EVA recycled pellets to an EVA foam compound and mixing them with each other, thereby enabling uniform foaming and thus realizing a good shape and improving the strength and quality of the product.

Abstract: The present invention relates to a liquid formulation comprising a TNFR-Fc fusion protein and a stabilizer, in which the fusion protein comprises TNFR (tumor necrosis factor receptor) or a fragment thereof and an immunoglobulin Fc region, and the stabilizer comprises one or more amino acids selected from the group consisting of proline and histidine, a buffer solution, and an isotonic agent containing sodium chloride (NaCl) and sucrose, and a preparation method of the liquid formulation. The liquid formulation according to the present invention provides excellent storage stability because long-term storage of TNFR-Fc fusion protein (etanercept) is possible and particular storage conditions are not needed.

Abstract: The present invention relates to a liquid formulation comprising a TNFR-Fc fusion protein and a stabilizer, in which the fusion protein comprises TNFR (tumor necrosis factor receptor) or a fragment thereof and an immunoglobulin Fc region, and the stabilizer comprises one or more amino acids selected from the group consisting of proline and histidine, a buffer solution, and an isotonic agent containing sodium chloride (NaCl) and sucrose, and a preparation method of the liquid formulation. The liquid formulation according to the present invention provides excellent storage stability because long-term storage of TNFR-Fc fusion protein (etanercept) is possible and particular storage conditions are not needed.